Molecular characterization of the new defective Pbrescia alpha1-antitrypsin allele

Human Mutation

Volumn 30, Issue 8, 2009, Pages

  Medicina, Daniela ^a   Montani, Nadia ^a   Fra, Anna M ^a   Tiberio, Laura ^a   Corda, Luciano ^b   Miranda, Elena ^c   Pezzini, Alessandro ^d   Bonetti, Fausta ^a   Ingrassia, Rosaria ^a   Scabini, Roberta ^e   Facchetti, Fabio ^a   Schiaffonati, Luisa ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Division of Internal Medicine   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Stroke Unit   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

1AT polymers; Alpha1 antitrypsin deficiency; Liver disease; Lung disease; SERPINA1

Indexed keywords

ALPHA 1 ANTITRYPSIN; POLYMER;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE REPORT; CHILD; ENDOPLASMIC RETICULUM; HUMAN; LIVER CELL; LIVER DISEASE; LIVER HISTOLOGY; LUNG DISEASE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ALLELES; ALPHA 1-ANTITRYPSIN; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 67749103747     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.21043     Document Type: Article

References (27)

1. Andolfatto S, Namour F, Garnier AL, Chabot F, Gueant JL, Aimone-Gastin I. 2003. Genomic DNA extraction from small amounts of serum to be used for alpha1-antitrypsin genotype analysis. Eur Respir J 21(2):215-9.
2. Brantly M, Nukiwa T, Crystal RG. 1988a. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 84(6A):13-31.
3. Brantly M. 1996. Alpha 1-antitrypsin genotypes and phenotypes. New York: Marcel Dekker Inc.
4. DeMeo DL, Silverman EK. 2004. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59(3):259-64.
5. Elliott PR, Pei XY, Dafforn TR, Lomas DA. 2000. Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci 9(7):1274-81.
6. Evans MD, Pryor WA. 1994. Cigarette smoking, emphysema, and damage to alpha 1-proteinase inhibitor. Am J Physiol 266(6 Pt 1):L593-611.
7. Ferrarotti I, Scabini R, Campo I, Ottaviani S, Zorzetto M, Gorrini M, Luisetti M. 2007. Laboratory diagnosis of alpha1- antitrypsin deficiency. Transl Res 150(5):267-74.
8. Fischer HP, Ortiz-Pallardo ME, Ko Y, Esch C, Zhou H. 2000. Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ. J Hepatol 33(6):883-92.
9. Fagerhol MK. 1968. The Pi-system: genetic variants of serum alpha-1-antitrypsin. Series Haematologica 1: 153-161.
10. Gadek J, Crystal R. 1982. Metabolic basis of inherited disease. Minneapolis, MN: McGraw-Hill Publications.
11. Greene CM, Miller SD, Carroll T, McLean C, O'Mahony M, Lawless MW, O'Neill SJ, Taggart CC, McElvaney NG. 2008. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. J Inherit Metab Dis 31(1):21-34.
12. Janciauskiene S, Eriksson S, Callea F, Mallya M, Zhou A, Seyama K, Hata S, Lomas DA. 2004. Differential detection of PASpositive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha1-antitrypsin. Hepatology 40(5):1203-10.
13. Lomas DA, Elliott PR, Sidhar SK, Foreman RC, Finch JT, Cox DW, Whisstock JC, Carrell RW. 1995. alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem 270(28):16864-70.
14. Lomas DA, Evans DL, Finch JT, Carrell RW. 1992. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357(6379):605-7.
15. Lomas DA, Finch JT, Seyama K, Nukiwa T, Carrell RW. 1993. Alpha 1-antitrypsin Siiyama (Ser53→Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem 268(21):15333-5.
16. Luisetti M, Seersholm N. 2004. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 59(2):164-9.
17. Mahadeva R, Chang WS, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, Wight DG, Lomas DA. 1999. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest 103(7):999-1006.
18. Miranda E, Romisch K, Lomas DA. 2004. Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J Biol Chem 279(27):28283-91.
19. Mulgrew AT, Taggart CC, McElvaney NG. 2007. Alpha-1-antitrypsin deficiency: current concepts. Lung 185(4):191-201.
20. Perlmutter DH. 2002. Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest 110(11):1579-83.
21. Perlmutter DH. 2009. Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency. Cell Death Differ 16(1):39-45.
22. Poller W, Merklein F, Schneider-Rasp S, Haack A, Fechner H, Wang H, Anagnostopoulos I, Weidinger S. 1999. Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Eur J Hum Genet 7(3):321-31.
23. Ranes J, Stoller JK. 2005. A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med 26(2):154-66.
24. Regev A, Guaqueta C, Molina EG, Conrad A, Mishra V, Brantly ML, Torres M, De Medina M, Tzakis AG, Schiff ER. 2006. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. J Pediatr Gastroenterol Nutr 43 Suppl 1:S30-5.
25. Stoller JK, Aboussouan LS. 2005. Alpha1-antitrypsin deficiency. Lancet 365(9478):2225-36.
26. Teckman JH, Perlmutter DH. 1996. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1- antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem 271(22):13215-20.
27. Wu Y, Swulius MT, Moremen KW, Sifers RN. 2003. Elucidation of the molecular logic by which misfolded alpha 1- antitrypsin is preferentially selected for degradation. Proc Natl Acad Sci U S A 100(14):8229-34.